We are live on ! Find out more
NUTX icon

Nutex Health

59 hedge funds and large institutions have $7.1M invested in Nutex Health in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 12

27% more capital inflows, than outflows

Capital inflows: $4.73M | Capital outflows: $3.74M

0.76% more ownership

Funds ownership: 4.53% → 5.3% (+0.76%)

20% less funds holding

Funds holding: 74 → 59 (-15)

56% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 25

Holders
59
Holders Change
-15
Holders Change %
-20.27%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
12
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NUTX Hedge Fund Activity: Q3 2023 in Review

59 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q3 2023, worth a combined $7.1M — down 45% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of NUTX and 11 opened new positions — a net loss of 14 holders — while 12 trimmed existing stakes and 17 added.

The largest buyer was BlackRock, adding an estimated $1.48M. The largest seller was Millennium Management, exiting entirely with an estimated $879K sold.

  • 59 institutional investors held Nutex Health (NUTX) as of Q3 2023, down from 74 in Q2 2023.
  • Funds reported $7.1M of Nutex Health stock for Q3 2023, down 45% quarter-over-quarter.
  • 11 funds opened new Nutex Health positions in Q3 2023 and 25 closed out, a net change of -14 holders.
  • The largest Nutex Health buyer in Q3 2023 was BlackRock, an estimated $1.48M added.
  • The largest Nutex Health seller in Q3 2023 was Millennium Management, an estimated $879K sold.

Based on aggregated 13F filings for Q3 2023.